"Harmony Medical Research Institute (HMRI) is a multi-specialty research site concentrated in Phase II, III and IV of clinical trials with the aim of helping the discovery of new treatments for treating diseases. Harmony Medical Research Institute is affiliated with a network of specialized Physicians all dedicated to boost the development and advancement of drugs."

During the past decade, Harmony Medical Research Institute conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harmony Medical Research Institute" #1 sponsor was "Celgene" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "Galecto Biotech AB" with 1 trials sponsored and "PureTech" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harmony Medical Research Institute" #1 collaborator was "Syneos Health" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Harmony Medical Research Institute" are "Crohn Disease" (4 trials), "Crohn's Disease" (1 trials), "Hypertriglyceridemia" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Idiopathic Pulmonary Fibrosis (IPF)" (1 trials). Many other conditions were trialed in "Harmony Medical Research Institute" in a lesser frequency.

Most popular intervention types in "Harmony Medical Research Institute" are "Drug" (12 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ozanimod" (3 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Harmony Medical Research Institute" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Harmony Medical Research Institute". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Harmony Medical Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Harmony Medical Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".